Tag: HistoSonics
#HOPE4LIVER trial demonstrates safety and efficacy of histotripsy for liver tumours
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark) played host to another FIRST@CIRSE session, which saw...
HistoSonics announces first kidney tumour treatment using histotripsy
HistoSonics has announced the first kidney patient has been treated using its histotripsy platform. The procedure was performed at the Leeds Teaching Hospitals NHS...
HistoSonics receives FDA breakthrough device designation for novel sonic beam therapy
HistoSonics has revealed that the US Food and Drug Administration (FDA) has granted the company breakthrough device designation for its new histotripsy targeted liver...
